Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

55.84 +1.19 (+2.18%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 539,127
Open 55.36
Bid (Size) 55.84 (12)
Ask (Size) 55.87 (6)
Prev. Close 54.65
Today's Range 54.99 - 55.94
52wk Range 23.51 - 87.47
Shares Outstanding 67,604,097
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference
From Lantheus Holdings, Inc.
Via Globe NewsWire
Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT Biopharma
From Lantheus Holdings, Inc.
Via Globe NewsWire

Performance

YTD
+10.20%
+10.20%
1 Month
+13.73%
+13.73%
3 Month
-24.55%
-24.55%
6 Month
-26.30%
-26.30%
1 Year
+125.53%
+125.53%

More News

Read More
Cramer's Take On This Stock Up 48% Year-To-Date: 'I Would Not Want To Come In At This Level'
Via Benzinga
Looking Into Lantheus Holdings's Return On Capital Employed
Via Benzinga
Lantheus Holdings: Q3 Earnings Insights
Via Benzinga
Lantheus Grants Rights for the Use of its Microbubbles to SonoThera for its Ultrasound-Guided Nonviral Gene Therapy Platform
From Lantheus Holdings, Inc.
Via Globe NewsWire
Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027
From Lantheus Holdings, Inc.
Via Globe NewsWire
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Lantheus Holdings, Inc. Announces Proposed Offering of $500 Million Convertible Senior Notes due 2027
From Lantheus Holdings, Inc.
Via Globe NewsWire
Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating
Via Investor's Business Daily
Lantheus Announces Appointment of Amanda Morgan as Senior Vice President, Commercial
From Lantheus Holdings, Inc.
Via Globe NewsWire
Lantheus Announces the Approval of DEFINITY® (Perflutren Lipid Microsphere) by China’s NMPA
From Lantheus Holdings, Inc.
Via Globe NewsWire
7 Index Funds to Buy to Retire a Millionaire
Via InvestorPlace
3 Stocks That Could Be the Next Big M&A Targets
Via InvestorPlace
These 3 Stocks Are Crushing the Market. Wall Street Thinks They Can Soar at Least 78% Higher.
Via The Motley Fool
PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday
Via Benzinga
Lantheus-POINT Biopharma Ink Strategic Collaboration For Cancer Programs
Via Benzinga
Lantheus and POINT Biopharma Announce Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003
From Lantheus Holdings, Inc.
Via Globe NewsWire
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Via MarketBeat
Topics Stocks
Exposures US Equities
Lantheus to Present at the Jefferies London Healthcare Conference
From Lantheus Holdings, Inc.
Via Globe NewsWire
Jim Cramer Says Tesla Has 'The Worst Chart I've Ever Seen': Is He Still A Believer?
Via Benzinga
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
Via Benzinga
Lantheus Reports Third Quarter 2022 Financial Results
From Lantheus Holdings, Inc.
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.